Last February, Alice Gilman, the cofounder and chief operating officer of a secretive Silicon Valley longevity startup called R3 Bio, sat for an interview with podcast Skyline Drive. In the interview, she discussed R3 Bio’s aspirations to grow nonsentient humanoid life-forms — from which, in theory, they can grow and harvest organs for implantation into human bodies, or to test future drugs and other treatments without the need for live animal testing.
“It’s just pretty much a heart, lungs, and everything that you would find in a body,” Gilman tells host and journalist Mangesh Hattikudur. “But it’s not technically alive because it’s exclusively the organs. And they’re in this little biological platform that you can test on and you can map out the cross-organ interactions.”
Throughout their conversation, as Hattikudur notes, Gilman refers to these imagined unfeeling meat suits — which will ideally be born without brains — as “organ sacks.” Needless to say, it’s an ambitious (and to many, fundamentally unsettling) concept that raises plenty of nagging bioethical questions — a reality that the company is clearly wrestling with as it entertains the idea in public.
“I try to not be scary to an average person,” Gilman told Hattikudur.
